Iron­wood looks to boost gout fran­chise as FDA de­liv­ers OK for Duza­l­lo

Iron­wood Phar­ma­ceu­ti­cals $IR­WD is on track to boost­ing its gout drug fran­chise with the launch of Duza­l­lo, a com­bo ther­a­py that match­es lesin­u­rad and al­lop­uri­nol …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER